NCT03210103View on ClinicalTrials.gov

Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

August 15, 2028

Study Completion Date

August 15, 2028

Conditions
Oropharyngeal Cancer
Interventions
RADIATION

Radiation

Standard of Care: Radiation +/- Chemotherapy

PROCEDURE

Transoral Surgery (TOS) + Neck Dissection

Transoral Surgery (TOS) + Neck Dissection (plus radiation, if required)

Trial Locations (9)

Unknown

Gold Coast University Hospital, Gold Coast

Royal Adelaide Hospital, Adelaide

T2N 4N2

Tom Baker Cancer Centre, Calgary

V5Z 1G1

BC Cancer, Vancouver

N6A 4L6

London Regional Cancer Program, London

K1Y 4E9

Ottawa Hospital Research Institute, Ottawa

M4N 3M5

Sunnybrook Research Institute, Toronto

M5G 2C4

University Health Network, Toronto

H3T 1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03210103 - Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter